ASIX Stock Analysis: AdvanSix | NYSE
Chemicals | NYSE, USA | Market Cap: 546m USD | 12M Return: 3.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.59M
EPS Trend: -6.9%
Qual. Beats: 0
Rev. Trend: -40.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 9.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
AdvanSix Inc. (NYSE: ASIX) is an integrated chemistry company that manufactures and sells polymer resins, primarily Nylon 6, along with related chemical products. Its portfolio spans caprolactam (a feedstock for nylon production), ammonium sulfate fertilizers, acetone, and a range of intermediate chemicals such as phenol, cyclohexanone, and specialty amines. These products serve downstream markets including automotive components, adhesives, paints, coatings, water treatment, and pharmaceuticals. The company sells through both direct channels and distributors, marketing under brands including Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox.
As a commodity chemicals producer in the GICS Materials sector, AdvanSix operates on an integrated production model in which key feedstocks like caprolactam and phenol are manufactured internally before being converted into finished resins and chemicals. This vertical integration is common among nylon producers, as it provides cost control over volatile raw material inputs. The company was incorporated in 2016, spun out from Honeywell, and is headquartered in Parsippany, New Jersey.
- Caprolactam and nylon 6 pricing spreads drive segment margins
- Ammonium sulfate fertilizer demand tracks spring planting season
- Propane feedstock cost volatility pressures gross margins
- Asian caprolactam oversupply weighs on pricing power
| Net Income: 10.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -4.42 > 1.0 |
| NWC/Revenue: 5.40% < 20% (prev 4.31%; Δ 1.08% < -1%) |
| CFO/TA 0.06 > 3% & CFO 96.1m > Net Income 10.4m |
| Net Debt (565.1m) to EBITDA (95.7m): 5.90 < 3 |
| Current Ratio: 1.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.0m) vs 12m ago -1.13% < -2% |
| Gross Margin: 7.44% > 18% (prev 13.05%; Δ -5.61% > 0.5%) |
| Asset Turnover: 92.82% > 50% (prev 95.85%; Δ -3.03% > 0%) |
| Interest Coverage Ratio: 1.51 > 6 (EBIT TTM 14.2m / Interest Expense TTM 9.37m) |
| A: 0.05 (Total Current Assets 454.0m - Total Current Liabilities 370.4m) / Total Assets 1.71b |
| B: 0.38 (Retained Earnings 642.9m / Total Assets 1.71b) |
| C: 0.01 (EBIT TTM 14.2m / Avg Total Assets 1.67b) |
| D: 0.87 (Book Value of Equity 796.3m / Total Liabilities 914.5m) |
| Altman-Z'' = 2.52 = A |
| DSRI: 1.29 (Receivables 229.7m/179.3m, Revenue 1.55b/1.56b) |
| GMI: 1.75 (GM 13.05% / 7.44%) |
| AQI: 0.95 (AQ_t 0.08 / AQ_t-1 0.08) |
| SGI: 0.99 (Revenue 1.55b / 1.56b) |
| TATA: -0.05 (NI 10.4m - CFO 96.1m) / TA 1.71b) |
| Beneish M = -2.15 (Cap -4..+1) = BB |
As of August 02, 2026, the stock is trading at USD 20.06 with a total of 198,052 shares traded. Over the past week, the price has changed by -4.70%, over one month by +0.91%, over three months by -18.05% and over the past year by +3.30%.
Current recommended Stop Loss: 19.00 (which is 5.3% or 1.3 ATR below the current price).
AdvanSix has no consensus analysts rating.
| Analysts Target Price | 23.5 | 17.1% |
P/E Trailing = 56.25
P/S = 0.3525
P/B = 0.7127
Revenue TTM = 1.55b USD
EBIT TTM = 14.2m USD
EBITDA TTM = 95.7m USD
Long Term Debt = 270.0m USD (from longTermDebt, last quarter)
Short Term Debt = 43.7m USD (from shortTermDebt, last quarter)
Debt = 582.7m USD (from shortLongTermDebtTotal, last quarter) + Leases 156.4m
Net Debt = 565.1m USD (calculated: Debt 582.7m - CCE 17.6m)
Enterprise Value = 1.11b USD (545.9m + Debt 582.7m - CCE 17.6m)
Interest Coverage Ratio = 1.51 (Ebit TTM 14.2m / Interest Expense TTM 9.37m)
EV/FCF = -49.98x (Enterprise Value 1.11b / FCF TTM -22.2m)
FCF Yield = -2.00% (FCF TTM -22.2m / Enterprise Value 1.11b)
FCF Margin = -1.44% (FCF TTM -22.2m / Revenue TTM 1.55b)
Net Margin = 0.67% (Net Income TTM 10.4m / Revenue TTM 1.55b)
Gross Margin = 7.44% ((Revenue TTM 1.55b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = 0.94% (prev 7.60%)
Tobins Q-Ratio = 0.65 (Enterprise Value 1.11b / Total Assets 1.71b)
Interest Expense / Debt = 1.61% (Interest Expense 9.37m / Debt 582.7m)
Taxrate = 9.45% (5.14m / 54.4m)
NOPAT = 12.9m (EBIT 14.2m * (1 - 9.45%))
Current Ratio = 1.23 (Total Current Assets 454.0m / Total Current Liabilities 370.4m)
Debt / Equity = 0.73 (Debt 582.7m / totalStockholderEquity, last quarter 796.3m)
Debt / EBITDA = 5.90 (Net Debt 565.1m / EBITDA 95.7m)
Debt / FCF = -25.42 (negative FCF - burning cash) (Net Debt 565.1m / FCF TTM -22.2m)
Total Stockholder Equity = 813.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.62% (Net Income 10.4m / Total Assets 1.71b)
RoE = 1.28% (Net Income TTM 10.4m / Total Stockholder Equity 813.4m)
RoCE = 1.31% (EBIT 14.2m / Capital Employed (Equity 813.4m + L.T.Debt 270.0m))
RoIC = 0.94% (NOPAT 12.9m / Invested Capital 1.37b)
WACC = 5.29% (E(545.9m)/V(1.13b) * Re(9.38%) + D(582.7m)/V(1.13b) * Rd(1.61%) * (1-Tc(0.09)))
Discount Rate = 9.38% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 19.73 | Cagr: 0.11%
[DCF] Fair Price = unknown (Cash Flow -22.2m)
EPS Correlation: -6.86 | EPS CAGR: -6.48% | SUE: -0.38 | # QB: 0
Revenue Correlation: -40.63 | Revenue CAGR: -1.73% | SUE: 0.07 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.56 | Chg30d=-11.90% | Revisions=+25% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.42 | Chg30d=+8.97% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=1.44 | Chg30d=-5.90% | Revisions=+0% | GrowthEPS=-37.1% | GrowthRev=+10.8%
EPS next Year (2027-12-31): EPS=2.92 | Chg30d=+2.99% | Revisions=+0% | GrowthEPS=+103.8% | GrowthRev=+5.1%
[Analyst] Revisions Ratio: +29% (up=3, down=1)